Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Joy

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 26, 2009
Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study groupMelanie S Joy, Debbie S Gipson, Leslie Powell, et al.
Plos One|September 4, 2015
Complement Activation in Patients with Focal Segmental GlomerulosclerosisJoshua M Thurman, Maria Wong, Brandon Renner, et al.
Cellular Signalling|March 21, 2020
The effect of MEK1/2 inhibitors on cisplatin-induced acute kidney injury (AKI) and cancer growth in miceCarolyn N Brown, Daniel J Atwood, Deepak Pokhrel, et al.
British Journal of Clinical Pharmacology|March 3, 2012
Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitisMelanie S Joy, Mary La, Jinzhao Wang, et al.
Cancers|May 11, 2024
The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient CareS Joy Trybula, Mark W Youngblood, Constantine L Karras, et al.
Journal of Pharmacology & Clinical Toxicology|December 27, 2024
A Pharmacokinetic/Toxicodynamic Model of Cisplatin Nephrotoxicity Using the Kidney Injury Molecule-1 BiomarkerLauren E Thompson, Avisek Ghimire, Xia Wen, et al.
Therapeutic Drug Monitoring|March 13, 2018
Acute Kidney Injury Biomarkers Predict an Increase in Serum Milrinone Concentration Earlier Than Serum Creatinine-Defined Acute Kidney Injury in Infants After Cardiac SurgeryKatja M Gist, David S Cooper, Julia Wrona, et al.
Circulation|September 10, 2009
Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study)Jean-François Roux, Erica Zado, David J Callans, et al.
JAMA Oncology|April 24, 2025
Intravenous Magnesium and Cisplatin-Associated Acute Kidney InjuryShruti Gupta, Ilya G Glezerman, Jamie S Hirsch, et al.
International Journal of Molecular Sciences|April 3, 2021
Urinary Exosomes Identify Inflammatory Pathways in Vancomycin Associated Acute Kidney InjuryLinda Awdishu, Amy Le, Jordan Amato, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 26, 2009
Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study groupMelanie S Joy, Debbie S Gipson, Leslie Powell, et al.
Plos One|September 4, 2015
Complement Activation in Patients with Focal Segmental GlomerulosclerosisJoshua M Thurman, Maria Wong, Brandon Renner, et al.
Cellular Signalling|March 21, 2020
The effect of MEK1/2 inhibitors on cisplatin-induced acute kidney injury (AKI) and cancer growth in miceCarolyn N Brown, Daniel J Atwood, Deepak Pokhrel, et al.
British Journal of Clinical Pharmacology|March 3, 2012
Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitisMelanie S Joy, Mary La, Jinzhao Wang, et al.
Cancers|May 11, 2024
The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient CareS Joy Trybula, Mark W Youngblood, Constantine L Karras, et al.
Journal of Pharmacology & Clinical Toxicology|December 27, 2024
A Pharmacokinetic/Toxicodynamic Model of Cisplatin Nephrotoxicity Using the Kidney Injury Molecule-1 BiomarkerLauren E Thompson, Avisek Ghimire, Xia Wen, et al.
Therapeutic Drug Monitoring|March 13, 2018
Acute Kidney Injury Biomarkers Predict an Increase in Serum Milrinone Concentration Earlier Than Serum Creatinine-Defined Acute Kidney Injury in Infants After Cardiac SurgeryKatja M Gist, David S Cooper, Julia Wrona, et al.
Circulation|September 10, 2009
Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study)Jean-François Roux, Erica Zado, David J Callans, et al.
JAMA Oncology|April 24, 2025
Intravenous Magnesium and Cisplatin-Associated Acute Kidney InjuryShruti Gupta, Ilya G Glezerman, Jamie S Hirsch, et al.
International Journal of Molecular Sciences|April 3, 2021
Urinary Exosomes Identify Inflammatory Pathways in Vancomycin Associated Acute Kidney InjuryLinda Awdishu, Amy Le, Jordan Amato, et al.
Pageof 19